Andreas F Hottinger Selected Research

Andreas F Hottinger Research Topics

Disease

21	Neoplasms (Cancer) 05/2024 - 12/2009
12	Glioblastoma (Glioblastoma Multiforme) 04/2024 - 12/2011
11	Glioma (Gliomas) 10/2023 - 06/2011
6	Brain Neoplasms (Brain Tumor) 05/2024 - 04/2016
4	Lymphoma (Lymphomas) 01/2023 - 09/2007
3	Melanoma (Melanoma, Malignant) 12/2019 - 04/2011
2	Astrocytoma (Pilocytic Astrocytoma) 01/2022 - 01/2020
1	Myocarditis (Carditis) 12/2023
1	Myositis (Idiopathic Inflammatory Myopathies) 12/2023
1	Neoplasm Metastasis (Metastasis) 10/2023
1	Disease Progression 08/2023
1	Ischemic Stroke 07/2023
1	Hemorrhage 07/2023
1	Stroke (Strokes) 07/2023
1	Ovarian Neoplasms (Ovarian Cancer) 01/2023
1	Oligodendroglioma 01/2022
1	Medulloblastoma 11/2021
1	Vascular Remodeling 01/2021
1	COVID-19 01/2021
1	Multiple Pulmonary Nodules 01/2020
1	Hyperplasia 01/2020
1	Tuberous Sclerosis (Bourneville's Disease) 01/2020
1	Angiomyolipoma 01/2020
1	Lymphangioleiomyomatosis (Lymphangiomyomatosis) 01/2020
1	Demyelinating Diseases (Demyelinating Disease) 12/2019
1	Lung Diseases (Lung Disease) 12/2019
1	Spontaneous Remission 12/2019
1	Brain Diseases (Brain Disorder) 01/2019
1	Limbic Encephalitis (Paraneoplastic Limbic Encephalitis) 03/2018
1	Skin Neoplasms (Skin Cancer) 05/2016
1	Meningioma (Meningiomas) 12/2013
1	Human Influenza (Influenza) 01/2012
1	Meningeal Carcinomatosis 04/2011
1	Carcinogenesis 12/2009

Drug/Important Bio-Agent (IBA)

8	Temozolomide (Temodar)FDA LinkGeneric 11/2021 - 04/2011
5	Immune Checkpoint InhibitorsIBA 12/2023 - 01/2018
5	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 08/2023 - 06/2020
4	Bevacizumab (Avastin)FDA Link 01/2021 - 06/2011
3	Biomarkers (Surrogate Marker)IBA 07/2023 - 07/2011
3	Antimitotic AgentsIBA 01/2022 - 12/2015
2	Rituximab (Mabthera)FDA Link 01/2023 - 01/2012
1	Anesthetics (Anesthetic Agents)IBA 05/2024
1	RNA (Ribonucleic Acid)IBA 01/2024
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2023
1	Ceruloplasmin (Ferroxidase)IBA 10/2023
1	EnzymesIBA 08/2023
1	vorasidenibIBA 08/2023
1	PlatinumIBA 01/2023
1	lisavanbulinIBA 01/2023
1	Procarbazine (Matulane)FDA Link 01/2022
1	Vincristine (Oncovin)FDA LinkGeneric 01/2022
1	Lomustine (CCNU)FDA Link 01/2022
1	HhAntag691IBA 11/2021
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2021
1	AcidsIBA 11/2020
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 11/2020
1	Everolimus FDA Link 01/2020
1	Sirolimus (Rapamycin)FDA Link 01/2020
1	trans-sodium crocetinate (crocetin)IBA 01/2020
1	NivolumabIBA 12/2019
1	Chimeric Antigen ReceptorsIBA 01/2019
1	CytokinesIBA 01/2019
1	Natalizumab (Tysabri)FDA Link 03/2018
1	Oxidoreductases (Dehydrogenase)IBA 04/2016
1	Platelet-Derived Growth FactorIBA 12/2013
1	TrabectedinIBA 12/2013
1	TOR Serine-Threonine KinasesIBA 12/2013
1	IGF-I-IGFBP-3 complex FDA Link 02/2013
1	SteroidsIBA 01/2012
1	VaccinesIBA 01/2012
1	Influenza Vaccines (Influenza Vaccine)FDA Link 01/2012
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 12/2011
1	Matrix Metalloproteinases (MMPs)IBA 12/2011
1	Proteins (Proteins, Gene)FDA Link 07/2011
1	Tumor Biomarkers (Tumor Markers)IBA 07/2011
1	Methotrexate (Mexate)FDA LinkGeneric 09/2007

Therapy/Procedure

15	Therapeutics 04/2024 - 12/2009
9	Drug Therapy (Chemotherapy) 07/2023 - 01/2012
6	Immunotherapy 07/2023 - 01/2018
6	Radiotherapy 01/2022 - 09/2007
2	Chemoradiotherapy 04/2018 - 12/2015
1	Hypnosis (Mesmerism) 05/2024
1	Craniotomy 05/2024
1	Adjuvant Chemotherapy 01/2022
1	Aftercare (After-Treatment) 01/2021
1	Combined Modality Therapy 11/2020
1	Neurological Rehabilitation 04/2016